TY - JOUR
T1 - Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern allogeneic stem cell transplantation
AU - Foster, Aaron E.
AU - Gottlieb, David J.
AU - Sartor, Mary
AU - Hertzberg, Mark S.
AU - Bradstock, Kenneth F.
N1 - Funding Information:
A. Foster was supported by the FH Loxton Postgraduate Scholarship, of the University of Sydney. We are grateful to Mrs. M. McGurgan of the Blood and Marrow Transplant Service for assistance in obtaining patient samples.
PY - 2002
Y1 - 2002
N2 - Cytomegalovirus (CMV) is a common herpes virus that can cause significant morbidity and mortality in immuno-compromised individuals, particularly those undergoing allogeneic stem cell transplantation (SCT) for hematological malignancies. Recent studies have examined the kinetics of CMV-specific CD8+ T-cell reconstitution after SCT transplantation and have found virus-specific cytotoxic T-lymphocyte regeneration to be dependent on CMV serologic status and CMV reactivation events. However, the reconstitution kinetics of CMV-specific CD4+ T-cells under these same circumstances were not addressed. In this study, we used HLA class I peptide tetramer for CMV pp65 and cytokine flow cytometry to follow the reconstitution of both CD4+ and CD8+ CMV-specific T-cells after allogeneic SCT. We found that following SCT in which both donors and recipients are CMV seropositive, virus-specific CD4+ T-helper cells show the same reconstitution kinetics as CD8+ cytotoxic T-cells. Following CMV reactivation, a synchronous but temporary increase in both CD4+ and CD8+ CMV-specific lymphocytes occurs. The pattern repeats itself after subsequent episodes of CMV reactivation. These data imply that both CD4+ and CD8+ lymphocytes are necessary for an efficient immune response to CMV and suggest that CD4+ and CD8+ CMV-specific T-cells are required for the complete restoration of CMV immunity. These findings may have important implications in the development of CMV-specific adoptive immunotherapy strategies.
AB - Cytomegalovirus (CMV) is a common herpes virus that can cause significant morbidity and mortality in immuno-compromised individuals, particularly those undergoing allogeneic stem cell transplantation (SCT) for hematological malignancies. Recent studies have examined the kinetics of CMV-specific CD8+ T-cell reconstitution after SCT transplantation and have found virus-specific cytotoxic T-lymphocyte regeneration to be dependent on CMV serologic status and CMV reactivation events. However, the reconstitution kinetics of CMV-specific CD4+ T-cells under these same circumstances were not addressed. In this study, we used HLA class I peptide tetramer for CMV pp65 and cytokine flow cytometry to follow the reconstitution of both CD4+ and CD8+ CMV-specific T-cells after allogeneic SCT. We found that following SCT in which both donors and recipients are CMV seropositive, virus-specific CD4+ T-helper cells show the same reconstitution kinetics as CD8+ cytotoxic T-cells. Following CMV reactivation, a synchronous but temporary increase in both CD4+ and CD8+ CMV-specific lymphocytes occurs. The pattern repeats itself after subsequent episodes of CMV reactivation. These data imply that both CD4+ and CD8+ lymphocytes are necessary for an efficient immune response to CMV and suggest that CD4+ and CD8+ CMV-specific T-cells are required for the complete restoration of CMV immunity. These findings may have important implications in the development of CMV-specific adoptive immunotherapy strategies.
KW - Allogeneic bone marrow transplantation
KW - CMV reactivation
KW - Cytokine flow cytometry
KW - Cytotoxic T-lymphocyte
UR - http://www.scopus.com/inward/record.url?scp=0036401576&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036401576&partnerID=8YFLogxK
U2 - 10.1053/bbmt.2002.v8.pm12374455
DO - 10.1053/bbmt.2002.v8.pm12374455
M3 - Article
C2 - 12374455
AN - SCOPUS:0036401576
VL - 8
SP - 501
EP - 511
JO - Biology of Blood and Marrow Transplantation
JF - Biology of Blood and Marrow Transplantation
SN - 1083-8791
IS - 9
ER -